Tag: Abbisko
77.4% ORR! Abbisko to present the updated clinical phase Ib data...
SHANGHAI, May 28, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that the updated results of Phase Ib study...